Daniel D. Burgess, Director at Cidara Therapeutics, Inc. (CDTX), bought 3,000 shares at $16.00 ($48K) on 2015-04-20, disclosed to the SEC on 2015-04-21.
Open-market purchase of $48k CDTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| NBRV | BUY | 2018-08-02 | $99K | — | Filing → |
| SNTS | SELL | 2013-06-04 | $171K | — | Filing → |
| SNTS | SELL | 2013-05-02 | $143K | — | Filing → |